These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9592633

  • 1. IGF-I and diabetes in adolescence.
    Dunger DB, Acerini CL.
    Diabetes Metab; 1998 Apr; 24(2):101-7. PubMed ID: 9592633
    [Abstract] [Full Text] [Related]

  • 2. Recombinant IGF-I therapy in insulin-dependent diabetes mellitus.
    Savage MO, Dunger DB.
    Diabetes Metab; 1996 Jul; 22(4):257-60. PubMed ID: 8767172
    [Abstract] [Full Text] [Related]

  • 3. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus.
    Bereket A, Lang CH, Wilson TA.
    Horm Metab Res; 1999 Jul; 31(2-3):172-81. PubMed ID: 10226799
    [Abstract] [Full Text] [Related]

  • 4. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J, Urban M, Głowińska B, Urban B.
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [Abstract] [Full Text] [Related]

  • 5. Does recombinant human insulin-like growth factor-1 have a role in the treatment of diabetes?
    Dunger DB, Acerini CL.
    Diabet Med; 1997 Sep; 14(9):723-31. PubMed ID: 9300221
    [Abstract] [Full Text] [Related]

  • 6. Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.
    Thrailkill K, Quattrin T, Baker L, Litton J, Dwigun K, Rearson M, Poppenheimer M, Kotlovker D, Giltinan D, Gesundheit N, Martha P.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1181-7. PubMed ID: 9100593
    [Abstract] [Full Text] [Related]

  • 7. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM, Yuen K, White D, Mallard B, Dalton RN, Acerini CL, Dunger DB.
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
    [Abstract] [Full Text] [Related]

  • 8. Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.
    Saukkonen T, Amin R, Williams RM, Fox C, Yuen KC, White MA, Umpleby AM, Acerini CL, Dunger DB.
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4634-41. PubMed ID: 15356074
    [Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factors (IGFs) and IGF-I treatment in the adolescent with insulin-dependent diabetes mellitus.
    Dunger DB, Cheetham TD, Crowne EC.
    Metabolism; 1995 Oct; 44(10 Suppl 4):119-23. PubMed ID: 7476304
    [Abstract] [Full Text] [Related]

  • 10. Metabolic impact of puberty on the course of type 1 diabetes.
    Acerini CL, Williams RM, Dunger DB.
    Diabetes Metab; 2001 Sep; 27(4 Pt 2):S19-25. PubMed ID: 11787432
    [Abstract] [Full Text] [Related]

  • 11. Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus.
    Acerini CL, Patton CM, Savage MO, Kernell A, Westphal O, Dunger DB.
    Lancet; 1997 Oct 25; 350(9086):1199-204. PubMed ID: 9652560
    [Abstract] [Full Text] [Related]

  • 12. Normalization of the IGF-IGFBP axis by sustained nightly insulinization in type 1 diabetes.
    Ekström K, Salemyr J, Zachrisson I, Carlsson-Skwirut C, Ortqvist E, Bang P.
    Diabetes Care; 2007 Jun 25; 30(6):1357-63. PubMed ID: 17372150
    [Abstract] [Full Text] [Related]

  • 13. [Biological and clinical analyses of the mechanism of growth retardation and the effect of recombinant human insulin-like growth factor-1 (rhIGF-1) treatment on glucose metabolism and growth in leprechaunism with severe insulin resistant diabetes].
    Kato M.
    Hokkaido Igaku Zasshi; 1998 Nov 25; 73(6):613-25. PubMed ID: 10036618
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone insulin-like growth factor I axis in insulin-dependent diabetes mellitus.
    Dunger DB, Cheetham TD.
    Horm Res; 1996 Jul 25; 46(1):2-6. PubMed ID: 8854134
    [Abstract] [Full Text] [Related]

  • 15. Mecasermin (recombinant human insulin-like growth factor I).
    Rosenbloom AL.
    Adv Ther; 2009 Jan 25; 26(1):40-54. PubMed ID: 19198769
    [Abstract] [Full Text] [Related]

  • 16. The effects of recombinant human insulin-like growth factor I on growth hormone secretion in adolescents with insulin dependent diabetes mellitus.
    Cheetham TD, Clayton KL, Taylor AM, Holly J, Matthews DR, Dunger DB.
    Clin Endocrinol (Oxf); 1994 Apr 25; 40(4):515-22. PubMed ID: 8187319
    [Abstract] [Full Text] [Related]

  • 17. Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.
    Saukkonen T, Shojaee-Moradie F, Williams RM, Amin R, Yuen KC, Watts A, Acerini CL, Umpleby AM, Dunger DB.
    Diabetes; 2006 Aug 25; 55(8):2365-70. PubMed ID: 16873702
    [Abstract] [Full Text] [Related]

  • 18. Profound changes in the GH-IGF-I system in adolescent girls with IDDM: can IGFBP1 be used to reflect overall glucose regulation?
    Halldin MU, Hagenäs L, Tuvemo T, Gustafsson J.
    Pediatr Diabetes; 2000 Sep 25; 1(3):121-30. PubMed ID: 15016222
    [Abstract] [Full Text] [Related]

  • 19. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
    Peczyńska J, Urban M, Urban B, Głowińska B, Florys B.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004 Sep 25; 10(1):41-8. PubMed ID: 15355738
    [Abstract] [Full Text] [Related]

  • 20. Effect of IGF-I therapy on VLDL apolipoprotein B100 metabolism in type 1 diabetes mellitus.
    Christ ER, Carroll PV, Albany E, Umpleby AM, Lumb PJ, Wierzbicki AS, Sönksen PH, Russell-Jones DL.
    Am J Physiol Endocrinol Metab; 2002 May 25; 282(5):E1154-62. PubMed ID: 11934682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.